# Delivery Order #SPE2DP26F6422

Delivery Order for Dexamethasone Sodium under Long-Term Pharmaceutical Supply Contract

**Buyer:** Defense Logistics Agency

**Award Amount:** $141.89
**Ceiling:** $141.89

**Awarded:** June 08, 2026
**Period of Performance:** Jun 08, 2026 - Jun 23, 2026

**Identifier:** SPE2DP26F6422
**NAICS:** 424210

This award is a delivery order contract issued under a long-term definitive pharmaceutical supply contract held by DMS Pharmaceutical Group Inc., a pharmaceutical distributor specializing in supplying critical medications to federal health agencies. The procurement involves dexamethasone sodium, an essential pharmaceutical used in various medical treatments. This delivery order plays a significant role in maintaining essential drug inventories that support public health readiness and ongoing medical services. The scope includes the timely delivery of dexamethasone sodium within a defined short-term period in mid-2026, with performance occurring at the Park Ridge, Illinois location. The award is part of a broader strategic multi-year indefinite delivery vehicle contract ensuring continuous pharmaceutical provision. This contract was awarded through a competitive vehicle as an extension of the primary supply contract, reflecting a strategic approach to medical supply acquisition. It builds upon the parent long-term contract awarded to DMS Pharmaceutical Group that covers a wide range of critical medications to meet diverse medical needs over an extended performance period starting in 2025 and anticipated through 2038.

### Description

8512167726!DEXAMETHASONE SODIU

[View original record](https://www.usaspending.gov/award/CONT_AWD_SPE2DP26F6422_9700_SPE2DX25D9900_9700)